Results 121 to 130 of about 2,605,313 (261)

European mistletoe/Iscador® FAQ [PDF]

, 2003
Mistletoe (Viscum album) may be the most commonly used complementary cancer therapy in Europe today.
Staff, Clinic
core   +1 more source

Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy

International Journal of Gynecological Cancer, 2019
Objective In previous studies, neoadjuvant chemotherapy followed by interval debulking surgery was not inferior to primary cytoreductive surgery as initial treatment for advanced epithelial ovarian cancer. Our study aimed to compare surgical and survival
Y. Lyons, H. Reyes, M. Mcdonald, A. Newtson, E. Devor, D. Bender, M. Goodheart, J. Gonzalez Bosquet   +7 more
semanticscholar   +1 more source

Bases and foundations of the treatment of peritoneal carcinomatosis: Review article [PDF]

, 2016
Peritoneal carcinomatosis refers to a shedding or tumor that spreads to the peritoneal serosa and structures of the abdominal cavity. It is an entity with a poor prognosis.
Barrios Sánchez, P., Castro Mesta, Julio Fernando, González Guerrero, Juan Francisco, Villarreal Cavazos, Gerardo   +3 more
core  

Factors influencing long‐term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms

BJS Open, 2019
Pseudomyxoma peritonei (PMP) is a rare disease, most commonly of appendiceal origin. Treatment consists of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS–HIPEC).
W. J. Eden, Niels F. M. Kok, P. Snaebjornsson, Katarzyna Jóźwiak, K. Woensdregt, P. Bottenberg, Henk Boot, A. Aalbers   +7 more
semanticscholar   +1 more source

Cytoreduction and Hyperthermic Intrathoracic Chemotherapy for Metastatic Pseudomyxoma Peritonei

Annals of Thoracic Surgery Short Reports
Pleural extension of pseudomyxoma peritonei is rare, and treatment demands multidisciplinary care. Perioperative management during cytoreductive surgery and hyperthermic intrathoracic chemotherapy challenges anesthesiology and surgical teams in unique ...
Luke J. Matzek, MD, Jaelin J. Otta, MD, Ryan E. Hofer, MD, Charles R. Sims, 3rd, MD, Mitchell J. Kerfeld, MD, Thomas M. Stewart, MD, Travis E. Grotz, MD, Luis F. Tapias, MD   +7 more
doaj   +1 more source

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer

Cancers, 2019
The management of peritoneal metastases from gastric cancer origin has evolved considerably over the last three decades with the establishment of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) as efficacious therapies ...
Adriana C. Gamboa, J. Winer
semanticscholar   +1 more source

Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations

Current Oncology
Peritoneal metastasis is a common finding in patients with advanced gastric cancer. Beyond systemic chemotherapy, additive local treatments such as cytoreductive surgery and intraperitoneal chemotherapy are considered an inherent part of different ...
Miklos Acs, Pompiliu Piso, Gabriel Glockzin   +2 more
doaj   +1 more source

Cytoreductive surgery for men with metastatic prostate cancer

Prostate International, 2016
Background: Cytoreductive surgery for metastatic prostate cancer is an emerging area of interest with a potential upside that includes local control, delayed initiation of hormone therapy, and possibly improved cancer specific survival.
Nikolas Katelaris, Declan Murphy, Nathan Lawrentschuk, Athos Katelaris, Daniel Moon   +4 more
doaj   +1 more source

Does neoadjuvant chemotherapy reduce surgical complexity in patients with advanced-stage epithelial ovarian cancer?

BMC Women's Health
Background This study aimed to determine the effect of neoadjuvant chemotherapy (NACT) on the complex surgical procedures required in addition to staging surgery for the need to achieve a residual tumor 1 cm or less in a population of stage IIIC–IV ...
Okan Aytekin, Simge Kirmizigul Kerinc, Abdurrahman Alp Tokalioglu, Yesim Ozkaya Ucar, Fatih Kilic, Gunsu Kimyon Comert, Gokhan Ucar, Burak Civelek, Taner Turan   +8 more
doaj   +1 more source

Aerosolization of nanotherapeutics as a newly emerging treatment regimen for peritoneal carcinomatosis

, 2019
Recent advances in locoregional chemotherapy have opened the door to new approaches for the clinical management of peritoneal carcinomatosis (PC) by facilitating the delivery of anti-neoplastic agents directly to the tumor site, while mitigating adverse ...
Ceelen, Wim, De Smedt, Stefaan, Remaut, Katrien, Shariati, Molood, Willaert, Wouter   +4 more
core   +1 more source